The role of Neuroligin 2 in the regulation of GABAergic interneuron activity and cortical inhibition
The role of Neuroligin 2 in the regulation of GABAergic interneuron activity and cortical inhibition
批准号:
10132749
负责人:
Colleen Michelle Brady
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2022-06-30
关键词:
AddressCellsCerebral cortexDataDiseaseElectroencephalographyElectrophysiology (science)Enterobacteria phage P1 Cre recombinaseFamilyFamily memberFrequenciesFunctional disorderFutureGeneticGoalsImageIndividualInhibitory SynapseInterneuronsKnock-outKnowledgeLeadMaintenanceMediatingMissionMolecularMutationOutputPathogenesisPharmacologyPhysiologyPlayProbabilityProtein FamilyProteinsPublic HealthPyramidal CellsRegulationResearchRoleSchizophreniaShapesSliceSomatostatinSymptomsSynapsesSynaptic MembranesSystemTestingTherapeuticUnited States National Institutes of HealthVasoactive Intestinal PeptideViralautism spectrum disorderbasecell typegenetic manipulationin vivoinhibitory neuroninsightmembermouse modelneuroligin 2neuropsychiatric disorderneuropsychiatric symptomneuroregulationnew therapeutic targetnovel strategiesoptogeneticspostsynapticpresynapticrecombinasespatiotemporalsynaptic inhibitiontargeted treatmentvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
GABAergic interneurons are critical for the maintenance of proper levels of cortical excitability. However, very
little is known about the mechanisms involved in the control of their activity. Specifically, there is a critical need
to understand the formation and maintenance of inhibitory synaptic inputs onto interneurons. Our long-term
goal is to gain a better understanding of the molecular mechanisms involved in the control of inhibitory
interneuron activity to allow for manipulation of synaptic inhibition in neuropsychiatric disorders where cortical
activity is disrupted. The overall goal is to determine the role of Neuroligin 2 (Nlgn2) in the regulation of this
inhibition and to better understand how loss of Nlgn2 alters the activity of the inhibitory interneurons and leads
to disease. The central hypothesis is that Nlgn2 plays an essential role in the regulation of inhibition onto
GABAergic interneurons and loss of Nlgn2 in interneurons leads to functional consequences on cortical activity
that may result in neuropsychiatric symptoms. Loss of Nlgn2 in somatostatin positive (Sst+) interneurons
results in a decrease in the frequency and amplitude of synaptic inhibitory inputs onto those cells. Aim one will
combine classical synaptic physiology and pharmacology with input-specific optogenetics to identify the
synaptic mechanisms that lead to alterations in inhibitory inputs onto Sst+ interneurons. Aim two will use in
vivo Ca2+ imaging and electroencephalography (EEG) recordings to determine the functional consequences of
loss of Nlgn2 in Sst+ interneurons on both cellular activity and overall cortical activity, respectively. These
important questions have yet to be addressed due to critical barriers including the inability to specifically
manipulate inhibitory synapses onto interneurons and the inability to directly test and manipulate the
connections between subtypes of interneurons in slice electrophysiology. This proposal overcomes these
barriers due to a novel approach that utilizes viral genetics, Cre recombinase, and FlpO recombinase, and the
specific manipulation of Nlgn2, a post-synaptic protein found exclusively at inhibitory synapses. The proposed
research is expected to elucidate the molecular mechanisms involved specifically in the regulation of cortical
interneuron activity. This contribution will be significant because it will allow for the manipulation of interneuron
activity to alter levels of cortical inhibition, serving as a novel therapeutic target therapy for neuropsychiatric
diseases in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Neuroligin 2 in the regulation of GABAergic interneuron activity and cortical inhibition
-
批准号:10399690
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2019
-
负责人:Colleen Michelle Brady
-
依托单位:
The role of Neuroligin 2 in the regulation of GABAergic interneuron activity and cortical inhibition
-
批准号:10347339
-
项目类别:
-
资助金额:$1.96万
-
财政年份:2019
-
负责人:Colleen Michelle Brady
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: